Ratings by Goldman Sachs (Evie Koslosky)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/5/2026 | Sotera Health | SHC | New Coverage | Buy (N/A) |
15.27 (18.89) |
23.71% | Details | |
| 6/5/2026 | GRAIL, Inc. | GRAL | New Coverage | Neutral (N/A) |
61.13 (68.94) |
12.78% | Details | |
| 6/5/2026 | Natera | NTRA | New Coverage | Neutral (N/A) |
211.85 (315.96) |
49.14% | Details | |
| 6/5/2026 | Guardant Health | GH | New Coverage | Buy (N/A) |
127.03 (165.11) |
29.98% | Details | |
| 4/13/2026 | Revvity Inc | RVTY | Maintain | Neutral (N/A) |
|
Details | ||
| 4/13/2026 | Danaher | DHR | Maintain | Buy (N/A) |
|
Details | ||
| 4/1/2026 | Caris Life Sciences Inc | CAI | New Coverage | Buy (N/A) |
17.88 (22.26) |
24.5% | Details | |
| 2/27/2026 | Agilent | A | Maintain | Buy (N/A) |
|
Details | ||
| 2/13/2026 | Bruker | BRKR | Maintain | Sell (N/A) |
|
Details | ||
| 12/9/2025 | Bruker | BRKR | New Coverage | Sell (N/A) |
48.03 (59.27) |
23.4% | Details | |
| 12/9/2025 | Mettler-Toledo | MTD | New Coverage | Neutral (N/A) |
1414.86 (1438.53) |
1.67% | Details | |
| 12/9/2025 | Revvity Inc | RVTY | New Coverage | Neutral (N/A) |
100.79 (117.88) |
16.96% | Details | |
| 12/9/2025 | Danaher | DHR | New Coverage | Buy (N/A) |
226.25 (205.79) |
-9.04% | Details | |
| 12/9/2025 | Agilent | A | New Coverage | Buy (N/A) |
145.49 (148.24) |
1.89% | Details | |
| 12/9/2025 | Thermo Fisher Scientific | TMO | New Coverage | Buy (N/A) |
572.77 (603.01) |
5.28% | Details |
